IL-6-mediated activation of STAT3 in colon cancer cell lines was shown to occur in conjunction with the phosphorylation (inactivation) of RKIP, leading to poor prognosis of colon cancer stage II patients. The gene discussed is STAT3; the disease is malignant colon neoplasm.